The National Institutes of Health has launched a study designed to determine whether approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19. If so, the NIH plans to help advance these therapies into larger clinical trials. Yourway is equipped to handle even the most profound clinical trials, regardless of where they take place. We have 21 depots strategically located around the world.